STOCK TITAN

Equus Total Return, Inc. 8-K Filings

EQS NYSE

Every 8-K that Equus Total Return, Inc. (EQS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow EQS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EQS filings page.

Rhea-AI Summary

Equus Total Return, Inc. (EQS) received a New York Stock Exchange notice on October 6, 2026, stating that its common stock’s average closing price was below $1.00 over a consecutive 30-trading-day period. The notice does not immediately affect listing or trading.

Equus plans to tell the NYSE by October 20, 2026, that it intends to cure the deficiency. It may regain compliance within six months after the notice if, on the last trading day of a calendar month during the cure period, its closing price is at least $1.00 and its 30-trading-day average ending that day is at least $1.00. The company is considering alternatives, including a reverse stock split. If it chooses an action requiring special-meeting stockholder approval, the price condition is met if the price promptly exceeds $1.00 and remains above that level for at least the following 30 trading days. Equus does not anticipate the notice affecting ongoing business operations or SEC reporting.

Rhea-AI Summary

Equus Total Return, Inc. reported the results of its annual stockholder meeting held on June 30, 2026. Stockholders holding 8,838,729 shares, or 63.28% of shares outstanding, were present in person or by proxy, providing a valid quorum.

All five director nominees were elected for one-year terms. Fraser Atkinson received 7,861,056 votes for and 977,673 withheld; Kenneth I. Denos received 4,405,506 for and 4,433,223 withheld; Henry W. Hankinson and John J. May each received 7,858,031 for and 980,698 withheld; and John A. Hardy received 7,604,223 for and 1,234,506 withheld. There were no votes cast against or abstentions for any nominee.

Stockholders also approved, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers in 2025, with 7,577,686 votes for, 1,219,066 against, and 41,977 abstentions. Brokers did not have discretionary voting authority on either proposal.

Rhea-AI Summary

Equus Total Return, Inc. reported net assets of $20.9 million as of March 31, 2026, and announced a first quarter net asset value update. Net asset value per share rose to $1.50 as of March 31, 2026, compared with $1.19 as of December 31, 2025.

The company’s shares outstanding were 13,967 at both March 31, 2026 and December 31, 2025, so the quarter’s NAV per-share change reflects movements in the value of its investment portfolio rather than share count changes. Equus is a business development company trading as a closed-end fund on the New York Stock Exchange under the symbol EQS.

Rhea-AI Summary

Equus Total Return, Inc. has engaged PKF O’Connor Davies, LLP as its independent accountant effective May 11, 2026. The company states it did not previously consult PKF on accounting principles, audit opinions, or financial reporting issues and reports no disagreements or reportable events under Regulation S-K related to this engagement.

Rhea-AI Summary

Equus Total Return, Inc. reported that its independent auditor, BDO USA, P.C., resigned effective April 29, 2026. BDO’s audit reports on the Fund’s financial statements for the years ended December 31, 2025 and 2024 were clean, with no adverse opinions or scope or principle qualifications.

The company states there were no disagreements with BDO on accounting, disclosure, or audit procedures and no reportable events other than previously disclosed material weaknesses. These weaknesses relate to management review controls over portfolio valuation and the handling of complex accounting transactions, including warrants. The weaknesses did not cause any identified misstatements but could potentially affect certain accounts and disclosures.

Rhea-AI Summary

Equus Total Return, Inc. reported net assets of $16.6 million as of December 31, 2025, with net asset value (NAV) per share of $1.19. This compares to net assets of $26.5 million and NAV per share of $1.90 as of September 30, 2025.

Shares outstanding were 13,967 at both December 31 and September 30, 2025, so the lower NAV per share reflects a decline in the value of the portfolio rather than share count changes. The company is a business development company trading as a closed-end fund on the NYSE under the symbol EQS.

Rhea-AI Summary

Equus Total Return, Inc. reported that it has released a press release announcing its net asset value for the quarter ended September 30, 2025. The company stated that this press release was issued on November 24, 2025 and has been attached as an exhibit to this report. Net asset value is a key measure for a closed-end fund, as it reflects the value of the fund’s portfolio on a per-share basis and helps investors understand how the share price compares to underlying holdings.

Rhea-AI Summary

Equus Total Return, Inc. filed a current report to note that it issued a press release on August 18, 2025 announcing its net asset value for the quarter ended June 30, 2025. The company states that the full text of this press release is provided as Exhibit 99.1 and is incorporated by reference. This update is mainly a formal notice that the quarter-end net asset value information has been publicly released through a separate document.